Contents

Current Pharmaceutical Design, Volume 18 - Number 22

Editorial [Hot Topic: New Treatment Strategy of the Myelodysplastic Syndromes]

, 18(22): 3147 - 3148

Kaoru Tohyama


DOI: 10.2174/1381612811209023147




World Health Organization Classification of Myelodysplastic Syndromes

, 18(22): 3149 - 3162

Magdalena Czader and Attilio Orazi


DOI: 10.2174/1381612811209023149




Genome-wide Analysis of Myelodysplastic Syndromes

, 18(22): 3163 - 3169

Masashi Sanada and Seishi Ogawa


DOI: 10.2174/1381612811209023163




Implication of microRNAs in the Pathogenesis of MDS

, 18(22): 3170 - 3179

Jing Fang, Melinda Varney and Daniel T. Starczynowski


DOI: 10.2174/1381612811209023170




5q- syndrome

, 18(22): 3180 - 3183

Jacqueline Boultwood, Andrea Pellagatti and James S. Wainscoat


DOI: 10.2174/1381612811209023180




Immunosuppressive Therapy for Myelodysplastic Syndromes

, 18(22): 3184 - 3189

Christiane Dobbelstein and Arnold Ganser


DOI: 10.2174/1381612811209023184




Utility of DNA Methyltransferase Inhibitors for the Treatment of Myelodysplastic Syndromes

, 18(22): 3190 - 3197

Kaoru Tohyama


DOI: 10.2174/1381612811209023190




Lenalidomide for Treatment of Myelodysplastic Syndromes

, 18(22): 3198 - 3203

Rami S. Komrokji and Alan F. List


DOI: 10.2174/1381612811209023198




Approach to New Therapeutics: Investigation by the Use of MDS-derived Cell Lines

, 18(22): 3204 - 3214

Takayuki Tsujioka, Akihito Matsuoka, Yumi Tohyama and Kaoru Tohyama


DOI: 10.2174/1381612811209023204




Current Status of Allogeneic Hematopoietic Cell Transplantation for MDS

, 18(22): 3215 - 3221

Feng Xu and H. Joachim Deeg


DOI: 10.2174/1381612811209023215




Pathophysiological and Clinical Aspects of Iron Chelation Therapy in MDS

, 18(22): 3222 - 3234

Norbert Gattermann


DOI: 10.2174/1381612811209023222




Editorial [Hot Topic: Preventive and Therapeutic Strategies for Transfusion-Related Acute Lung Injury]

, 18(22): 3235

Alexander P.J. Vlaar


DOI: 10.2174/1381612811209023235




Transfusion-related Acute Lung Injury: An Overview

, 18(22): 3236 - 3240

Behnaz Bayat and Ulrich J. Sachs


DOI: 10.2174/1381612811209023236




Prevention of Immune-mediated Transfusion-related Acute Lung Injury; from Bloodbank to Patient

, 18(22): 3241 - 3248

Marcella C.A. Muller, Leendert Porcelijn and Alexander P.J. Vlaar


DOI: 10.2174/1381612811209023241




Prevention of Non-immune Mediated Transfusion-related Acute Lung Injury; from Blood Bank to Patient

, 18(22): 3249 - 3254

Robin van Bruggen and Dirk de Korte


DOI: 10.2174/1381612811209023249




Therapeutic Options for Transfusion Related Acute Lung Injury; the Potential of the G2A Receptor

, 18(22): 3255 - 3259

Michael A. Ellison, Daniel R. Ambruso and Christopher C. Silliman


DOI: 10.2174/1381612811209023255




Platelet-neutrophil Interactions as a Target for Prevention and Treatment of Transfusion- related Acute Lung Injury

, 18(22): 3260 - 3266

Axelle Caudrillier and Mark R. Looney


DOI: 10.2174/1381612811209023260




Coagulopathy as a Therapeutic Target for TRALI: Rationale and Possible Sites of Action

, 18(22): 3267 - 3272

Pieter R. Tuinman, Marcus J. Schultz and Nicole P. Juffermans


DOI: 10.2174/1381612811209023267




State of the Art Management of Transfusion-Related Acute Lung Injury (TRALI)

, 18(22): 3273 - 3284

Andrew D. Goldberg and Daryl J. Kor


DOI: 10.2174/1381612811209023273




Future Preventive and Therapeutic Targets for Transfusion-Related Acute Lung Injury

, 18(22): 3285 - 3292

Brian R. Curtis


DOI: 10.2174/1381612811209023285




Insights on Biology and Pathology of HIF-1α/-2α, TGFβ/BMP, Wnt/β-Catenin, and NF-κB Pathways in Osteoarthritis

, 18(22): 3293 - 3312

Longhuo Wu, Xianhua Huang, Linfu Li, Hao Huang, Ruian Xu and Walter Luyten


DOI: 10.2174/1381612811209023293




Radiovirotherapy: Principles and Prospects in Oncology

, 18(22): 3313 - 3320

Y. Touchefeu, P. Franken and K. J. Harrington


DOI: 10.2174/1381612811209023313




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science